Serum soluble intercellular adhesion molecule-1, interleukin-8 and interleukin-6 levels in patients with Behcet's disease

Pain Clinic

Volumn 15, Issue 2, 2003, Pages 159-165

  Kiziltunç, Ahmet ^a   Yildirim, A Kadìr ^a   Keleş, M Saìt ^a   Koçer, Ìbrahìm ^a   Aksoy, Hülya ^a   Başoǧlu, Mahmut ^a   Yildirgan, Ilhan ^a   Özbey, Isa ^a   Aksoy, Yilmaz ^a   Karakuzu, Ali ^a   Aslan, Şahin ^a   Bakan, Ebubekìr ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Behcet's disease; Interleukin 6; Soluble intercellular adhesion molecule 1

Indexed keywords

C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; SOLUBLE INTERCELLULAR ADHESION MOLECULE 1; UNCLASSIFIED DRUG;

ADULT; APHTHOUS ULCER; ARTICLE; BEHCET DISEASE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; EYE INJURY; FEMALE; GENITAL ULCER; HUMAN; LABORATORY DIAGNOSIS; MALE; PROTEIN BLOOD LEVEL; SERUM; SKIN DEFECT;

EID: 0038353695     PISSN: 01691112     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856903321579280     Document Type: Article

References (32)

1. Yazici H, Yurdakul S, Hamuryudan V, Behcet's syndrome, Curr Opin Rheumatol 11, 53-7 (1999).
2. Sakane T, Takeno M, Suzuki N, Inaba G, Behcet's disease, New Engl J Med 341, 1284-91 (1999).
3. Direskeneli H, Eksioǧlu-Demiralp E, Akoǧlu T, Etiopathogenesis of Behcet's syndrome: recent developments and current controversies, Marmara Med J 12, 101-6 (1999).
4. Jabs DA, Rheumatic disease, in: Retina, Ryan SJ (Ed.), pp. 1426-7. Mosby, St Louis (2001).
5. Ohno S, Kato F, Matsuda H, Fujii N, Minagawa T, Detection of gamma interferon in the sera of patients with Behçet's disease, Infect Immun 36, 202-8 (1982).
6. Franks WA, Limb GA, Stanford MR, et al., Cytokines in human intraocular inflammation, Curr Eye Res 11, 187-94 (1992).
7. Goldstein IM, Malmsten CL, Samuelsson B, Weissmann G, Prostaglandins thromboxanes, and polymorphonuclear leukocytes: mediation and modulation of inflammation, Inflammation 2, 309-17 (1997).
8. Messadi DV, Pober JS, Fiers W, Gimbrone MA, Murphy GF, Induction of an activation antigen on postcapillary venular endothelium in human skin organ culture, J Immunol 139, 1557-62 (1987).
9. Hunkapiller T, Hood L, Diversity of the immunoglobulin gene superfamily, Adv Immunol 44, 1-63 (1989).
10. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD, A form of circulating ICAM-1 in human serum, J Immunol 147, 3788-93 (1991).
11. Seth R, Raymond FD, Makgoba MW, Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders, Lancet 338, 83-4 (1991).
12. Furukawa S, Imai K, Matsubara T, Yone K, Yachi A, Okamura K, Increased levels of circulating intercellular adhesion molecule-1 in kawasaki disease, Arthritis Rheum 35, 672-7 (1992).
13. Van Seventer GA, Shimizu Y, Horgan KJ, Shaw S, The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells, J Immunol 144, 45-79 (1989).
14. Wacholtz MC, Patel SS, Lipsky PE, Leukocyte function-associated antigen 1 is an activation molecule for human T cells, J Exp Med 170, 431 (1989).
15. Rot A, Endothelial cell binding of NAP1/IL-8: role in neutrophil emigration, Immunol Today 13, 291-41 (1992).
16. Gauldie J, Richards C, Harnish D, Lansdrop P, Baumann H, Interferon β2/B cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute protein response in liver cells, Proc Natl Acad Sci USA 84, 7251-5 (1987).
17. International Study Group for Behçet's Disease, Criteria for diagnosis of Behçet's disease, Lancet 335, 1078-80 (1990).
18. Franks WA, Limb GA, Stanford MR, Cytokines in human intraocular inflammation, Curr Eye Res 11, 187-94 (1992).
19. Nakamura S, Sugita M, Tanaka S, Ohno S, Enhanced production of in vitro tumor necrosis factor-alpha from monocytes in Behcet's disease, Acta Soc Ophthalmol Jpn 96, 1282-5 (1992).
20. Stegeman CA, Tervaert JWC, Huitema MG, Jong PE, Kallenberg CGM, Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and E selectin in patiens with Wegener's granulomatosis, Arthritis Rheum 37, 1228-35 (1994).
21. Dustin ML, Rothlein M, Bhan AK, Dinarello CA, Springer TA, Induction by IL-1 and interferon gamma:tissue distribution biochemistry and function of a natural adherence molecule (ICAM-1), J Immunol 137, 245-54 (1986).
22. Rothlein R, Czaykowski M, O'Neil MM, Martin SD, Mainolfi E, Merluzzi VJ, Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines, J Immunol 141, 1665-69 (1988).
23. Chin JI, Winterrowd GE, Krzescki RF, Sanders ME, Role of cytokines in inflammatory synovitis. The coordinate regulation of intercellular adhesion molecule-1 and HLA class 1 and Class II antigens in rheumatoid synovial fibroblasts, Arthritis Rheum 33, 1676-86 (1990).
24. Lindsley HB, Smith DD, Cohick CB, Koch AE, Davis LS, Proinflammatory cytokines enhance human synoviocyte expression of functional intercellular adhesion molecule-1 (ICAM-1), Clin Immunol Immunopathol 68, 311-20 (1993).
25. Zaman AG, Edelsten C, Stanford MR, et al., Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis, Clin Exp Immunol 95, 60-5 (1994).
26. Pigott R, Dillon LP, Hemingway IH, et al., Soluble forms of E selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells, Biochem Biophys Res Commun 187, 584-9 (1992).
27. Geargin AJH, Newman W, Circulating adhesion molecules in disease, Immunology Today 10, 506-12 (1993).
28. Cid MC, New developments in the pathogenesis of systemic vasculitis, Curr Opin Rheumatol 8, 1-11 (1996).
29. Hirano T, Matsuda T, Turner M, et al., Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis, Eur J Immunol 18, 1779-801 (1988).
30. Miyasaka N, Sato K, Hashimoto J, et al., Constitutive production of interleukin 6/B cell stimulatory factor-2 from inflammatory synovium, Clin Immunol Immunopathol 52, 238-47 (1989).
31. Suzuki Y, Saito H, Kasanuki J, Kishimoto T, Tamura Y, Yoshida S, Significant increase of interleukin-6 production in blood monnuclear leukocytes obtained from patients with active inflammatory bowel disease, Life Sci 47, 2193-7 (1990).
32. Linker-Israeli M, Deans R, Waalge D, Prehn J, Ozeri-Chen T, Klinenberg J, Elevated levels of endogenous IL-6 in systemic lupus erythematosus, J Immunol 147, 117-23 (1991).